Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Jeff Cauble, Vice President of Finance...
-
Sep 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Talent Board, a non-profit organization focused on the elevation and promotion of a quality candidate experience, today announced Talemetry, which combines the leading enterprise-grade recruitment...
-
Sep 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various...
-
Sep 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine,...
-
Sep 3, 2019Virtual Press Office and PR Newswire: General Trade show news
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients...